1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Analysis of Omics Data for Cancer Epidemiology and Health Disparities (R03 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI), National Human Genome Research Institute (NHGRI), National Institute of Dental and Craniofacial Research (NIDCR).
This funding opportunity encourages applications proposing to conduct secondary data analysis and integration of existing datasets and database resources to elucidate the genetic architecture of cancer risk and related outcomes.
The goal is to address key scientific questions relevant to cancer genomics and epidemiology by supporting the analysis of existing genetic or genomic datasets, in combination with other omics and environmental, clinical, behavioral, lifestyle, and molecular profiles data.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: The eligibility is not explicitly detailed in the provided snippet but typically includes institutions of higher education, non-profits, small businesses, and government entities. Applicants should consult the full FOA for specific eligibility requirements. Confirm the full requirements in the official notice before applying.
Analysis of Omics Data for Cancer Epidemiology and Health Disparities (R03 Clinical Trial Not Allowed) is funded by National Cancer Institute (NCI), National Human Genome Research Institute (NHGRI), National Institute of Dental and Craniofacial Research (NIDCR). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
On August 26, 2026, NSF named the STC class of 2026: TEMPEST at Michigan State, GENIE at Northwestern, and a human-robot co-adaptation center at UT Austin. $90 million total, $6 million a year each. The 2023 class was four centers and $120 million. The award size is intact; the shelf space shrank 25 percent — and that is the number that should reshape how you plan a center proposal.
Read articleWhile headlines chase AI and defense money, USDA's National Institute of Food and Agriculture runs a tight summer competitive cycle — Equipment Grants (June 25), Agricultural Genome to Phenome (June 29), New Beginning for Tribal Students (July 2), and Crop Protection and Pest Management (July 6). Here is how the four programs fit together, who is eligible, and why the land-grant system has a structural edge.
Read articleOn May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read article